Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Virology|January 9, 1999
Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivityS S Whitehead, C Y Firestone, R A Karron, et al.
The Journal of Infectious Diseases|December 12, 1997
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and childrenR A Karron, P F Wright, J E Crowe, et al.
Virus Research|April 1, 1994
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesB R Murphy, S L Hall, A B Kulkarni, et al.
The Journal of Infectious Diseases|January 1, 1996
Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care CenterM L Clements, M K Makhene, R A Karron, et al.
Bone Marrow Transplantation|July 1, 2014
Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomesS Seo, H Xie, R A Karron, et al.
The Pediatric Infectious Disease Journal|January 1, 1995
Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of ageR A Karron, M C Steinhoff, E K Subbarao, et al.
The Journal of Infectious Diseases|April 1, 1990
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cellsI B Weisfuse, D J Graham, M Will, et al.
The Journal of Infectious Diseases|March 1, 1993
Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challengeL F Fries, S B Dillon, J E Hildreth, et al.
The Journal of Infectious Diseases|May 1, 1995
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and childrenR A Karron, P F Wright, S L Hall, et al.
The Journal of Infectious Diseases|June 3, 1999
Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study GroupR A Karron, R J Singleton, L Bulkow, et al.
Pageof 3